{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:27:39Z","timestamp":1761870459561,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.clml.2012.09.014","type":"journal-article","created":{"date-parts":[[2012,11,15]],"date-time":"2012-11-15T16:50:57Z","timestamp":1352998257000},"page":"386-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The History of Leukemia Therapy\u2014A Personal Journey"],"prefix":"10.1016","volume":"12","author":[{"given":"Emil J.","family":"Freireich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1991","series-title":"Milestones in Leukemia Research and Therapy","author":"Freireich","key":"10.1016\/j.clml.2012.09.014_bib1"},{"key":"10.1016\/j.clml.2012.09.014_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.tmrv.2011.01.003","article-title":"Origins of platelet transfusion therapy","volume":"25","author":"Freireich","year":"2011","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.clml.2012.09.014_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.tmrv.2011.04.004","article-title":"Leukocyte transfusion and the development of the Continuous-flow Blood Cell separator","volume":"25","author":"Freireich","year":"2011","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.clml.2012.09.014_bib4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/1740774511407358","article-title":"The 6-MP versus placebo clinical trial in acute leukemia","volume":"8","author":"Gehan","year":"2011","journal-title":"Clin Trials"},{"key":"10.1016\/j.clml.2012.09.014_bib5","first-page":"2764","article-title":"Min Chiu Li: a perspective in cancer therapy","volume":"8","author":"Freireich","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2012.09.014_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0145-2126(87)90017-8","article-title":"Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia","volume":"11","author":"Keating","year":"1987","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2012.09.014_bib7","first-page":"500","article-title":"Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia","volume":"6","author":"Freireich","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2012.09.014_bib8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood.V72.3.893.bloodjournal723893","article-title":"Detection of minimal residual bcr\/abl transcripts by a modified polymerase chain reaction","volume":"72","author":"Lee","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.09.014_bib9","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/cncr.20668","article-title":"Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"101","author":"Kantarjian","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2012.09.014_bib10","first-page":"2594","article-title":"Recreating an environment for clinical discovery","volume":"3","author":"Gutterman","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2012.09.014_bib11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V92.4.1165","article-title":"Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy","volume":"92","author":"Keating","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.09.014_bib12","first-page":"131","article-title":"The usefulness of multiple pretreatment patient characteristic for prediction of response and survival in patients with adult acute leukemia","volume":"14","author":"Freireich","year":"1973","journal-title":"Adv Biosci"},{"key":"10.1016\/j.clml.2012.09.014_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3747\/co.v16i5.480","article-title":"The road to cancer control goes through leukemia research","volume":"16","author":"Freireich","year":"2009","journal-title":"Curr Oncol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226501200198X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226501200198X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:22:39Z","timestamp":1761870159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S215226501200198X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S215226501200198X"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2012.09.014","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The History of Leukemia Therapy\u2014A Personal Journey","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2012.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}